Aethlon Medical, Inc. (AEMD) |
|
0.6193 -0.041 (-6.17%)
|
02-03 15:18 |
|
Open: |
0.6606 |
Pre. Close: |
0.66 |
|
High:
|
0.6899 |
Low:
|
0.5901 |
|
Volume:
|
594,740 |
Market Cap:
|
14(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 3:15:07 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.01 One year: 1.18 |
| Support: |
Support1: 0.48 Support2: 0.25 |
| Resistance: |
Resistance1: 0.87 Resistance2: 1.01 |
| Pivot: |
0.52 |
| Moving Average: |
MA(5): 0.64 MA(20): 0.5
MA(100): 0.5  MA(250): 0.93 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 53.4 %D(3): 52.1 |
| RSI: |
RSI(14): 62.1 |
| 52-week: |
High: 2.46 Low: 0.23 |
| Average Vol(K): |
3-Month: 1,027 (K) 10-Days: 4,760 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AEMD ] has closed below upper band by 23.8%. Bollinger Bands are 52.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.72 - 0.72 |
0.72 - 0.73 |
|
Low:
|
0.65 - 0.65 |
0.65 - 0.65 |
|
Close:
|
0.65 - 0.66 |
0.66 - 0.66 |
|
Company Description |
|
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California. |
Headline News |
Tue, 31 Jan 2023
Is Aethlon Medical, Inc. (AEMD) a Good Buy in the Medical Devices Industry? - InvestorsObserver
Tue, 31 Jan 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Mon, 30 Jan 2023
Why Is Aethlon Medical (AEMD) Stock Up 50% Today? - InvestorPlace
Mon, 30 Jan 2023
Thinking about buying stock in Exela Technologies, Genius Group ... - PR Newswire
Mon, 30 Jan 2023
Aethlon Medical (AEMD) Announces Contract with NAMSA to ... - StreetInsider.com
Fri, 06 Jan 2023
Why Spruce Biosciences Shares Are Trading Higher By 100 ... - Investing.com UK
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
23 (M) |
|
% Held by Insiders
|
2.278e+007 (%) |
|
% Held by Institutions
|
1 (%) |
|
Shares Short
|
302 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-1.276e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
-0.5 |
|
EPS Est Next Year
|
-2 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-42 |
|
Return on Assets (ttm)
|
624.5 |
|
Return on Equity (ttm)
|
-34.4 |
|
Qtrly Rev. Growth
|
30230 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
-68.47 |
|
EBITDA (p.s.)
|
330528 |
|
Qtrly Earnings Growth
|
-0.7 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-11 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
-0.01 |
|
Price to Cash Flow
|
0.63 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
209890 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-10-14 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
